US gov­ern­ment, Pfiz­er and oth­ers side with Sanofi and Re­gen­eron in Supreme Court patent case

Pfiz­er, Vi­a­tris, the US gov­ern­ment and oth­ers on Fri­day sub­mit­ted briefs to the Supreme Court back­ing Sanofi and Re­gen­eron in their fight against Am­gen over patents that cov­er their PC­SK9 in­hibitors to con­trol cho­les­terol.

SCO­TUS will ad­dress what’s re­ferred to as the “en­able­ment” re­quire­ment, which es­sen­tial­ly spells out how a patent should in­clude both a writ­ten de­scrip­tion of an in­ven­tion, and the man­ner and process of mak­ing and teach­ing skilled ar­ti­sans “to make and use” the in­ven­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER